Financial Freedom LLC’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29K Buy
+111
New +$28.5K 0.01% 200
2026
Q2
– Sell
-111
Closed -$24.1K – 110
2026
Q1
$24.1K Hold
111
– – 0.01% 219
2025
Q4
$25.3K Hold
111
– – 0.01% 206
2025
Q3
$25.7K Hold
111
– – 0.01% 210
2025
Q2
$20.6K Buy
111
+1
+0.9% +$186 0.01% 225
2025
Q1
$23K Buy
110
+1
+0.9% +$194 0.01% 220
2024
Q4
$19.3K Buy
109
+1
+0.9% +$184 0.01% 227
2024
Q3
$21.3K Buy
108
+1
+0.9% +$187 0.01% 217
2024
Q2
$18.4K Buy
107
+1
+0.9% +$166 0.01% 228
2024
Q1
$19.3K Buy
106
+1
+1% +$172 0.01% 229
2023
Q4
$16.3K Buy
105
+1
+1% +$146 0.01% 239
2023
Q3
$15.5K Buy
104
+1
+1% +$147 0.01% 244
2023
Q2
$13.9K Buy
103
+1
+1% +$147 0.01% 244
2023
Q1
$16.2K Sell
102
-6
-6% -$917 0.01% 227
2022
Q4
$17.4K Buy
+108
New +$16.6K 0.01% 222

Other funds holding ABBV

Financial Freedom LLC's ABBV Position: Q3 2026 in Review

Financial Freedom LLC opened a new position in AbbVie (ABBV) in Q3 2026: 111 shares worth $29K. The stake represents 0.01% of the portfolio and ranks #200 among its holdings. This is a return to the name: Financial Freedom LLC previously reported a position in ABBV as recently as Q1 2026.

Financial Freedom LLC first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Financial Freedom LLC held 111 shares of AbbVie worth $29K as of Q3 2026.
  • AbbVie was a new Financial Freedom LLC position in Q3 2026.
  • AbbVie made up 0.01% of Financial Freedom LLC's portfolio in Q3 2026, its #200 holding.
  • Financial Freedom LLC first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Financial Freedom LLC's 13F filing for Q3 2026, filed 6 Nov 2026.